The Royal Victorian Eye and Ear Hospital is seeking patients for a phase II clinical study of Okogen’s OKG-0301 to treat viral conjunctivitis.In partnership with the Centre for Eye Research Australia
Amazon has announced a new feature of the Alexa voice command device now allows UK users to have health queries answered by the National Health Service. A Department of Health news release said the
University of Michigan researchers have developed technology to help clinicians “see” and map patient pain in real-time, through special augmented reality (AR) glasses.Using the portable CLARAi
Phase III optical trials of teprotumumab have proved effective in the treatment of active thyroid eye disease (TED), moving the monoclonal antibody treatment closer to becoming the first approved
Medsafe has opened a public consultation on plans to introduce new labelling requirements for non-active substances in medicines that may cause allergic reactions.Group Manager Chris James said: “The
Australian and UK optometrists have developed new guidelines to help prevent falls in older patients. Created in a collaboration between Queensland University of Technology and the University of
Australia’s national diabetes eye screening programme Keepsight is to receive a $1.3 million boost, the Government announced during National Diabetes Awareness Week (July 14-20).The funding comes on
French designer Christophe Pillet has been announced as chairman of the Silmo d’Or jury 2019.Silmo organisers said the Paris-based interior architect was internationally renowned for his “clear
University of Auckland researchers say affordable, infrared eye tracking could be more effective than current standard clinical tests at detecting and measuring strabismus in patients. The School of
Further statistics on the rise of myopia were presented by Review of Myopia Management at the American Optometric Association’s Myopia Matters meeting in late June. On behalf of the Review, Jobson
US biotech company Invitae has launched ID your IRD, to offer free genetic testing to patients suspected by their healthcare providers of having an inherited retinal disease (IRD). Invitae’s Dr
Re:Vision’s new Co-Management Conference on Sunday 11 August to be held at its surgery in Mt Wellington, Auckland, promises to be the first of its kind in New Zealand, said organisers.
